Could a drug intended to prevent painful rashes also protect our brains as we get older? The signs are promising – but not conclusive. Yet that’s enough to be driving a boom in shingles jabs
In today’s newsletter: Reversible male hormonal contraception could reach the market within five to 10 years. But why has this development been so slow?
Since the ancient Olympics, athletes like Hyrox competitor Joanna Wietrzyk have experienced runner’s diarrhoea. What does the science say about extreme exercise’s ‘mechanical jostling of the intestines’?
CEOs may like to get up at the crack of dawn and go for a run, but I prefer optimising my life with lie-ins, trashy films, swearing and coffee, writes Arwa Mahdawi